Skip to main content
Fig. 1 | Trials

Fig. 1

From: Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial

Fig. 1

Patient flow through the standard of care and intervention arms of the study

*The number of clinic visits has changed during the COVID pandemic. In practice, patients are provided with a 1- to 2-week supply of medication at a time unless the healthcare workers’ assessment signals adherence as a potential concern. TB, tuberculosis; DAT, digital adherence technologies; HCWs, healthcare workers

Back to article page